IM Cannabis Corp. (IMCC)

Market Cap	5.69M
Revenue (ttm)	38.04M
Net Income (ttm)	-9.52M
Shares Out	2.97M
EPS (ttm)	-4.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,898
Open	1.950
Previous Close	2.030
Day's Range	1.910 - 2.200
52-Week Range	1.134 - 8.100
Beta	1.68
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About IMCC

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1980
• Employees: 95
• Stock Exchange: NASDAQ
• Ticker Symbol: IMCC
• Website: https://imcannabis.com

Financial Performance

In 2023, IM Cannabis's revenue was 48.80 million, a decrease of -10.18% compared to the previous year's 54.34 million. Losses were -9.50 million, -94.97% less than in 2022.

Financial numbers in CAD